← Back to Search

Disinfecting Solution

Cleaning Solutions for Contact Lens Hygiene

N/A

Waitlist Available

Research Sponsored by Alcon Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Must not have

Any ocular disease or condition that would contraindicate contact lens wear

Use of systemic or ocular medication that would contraindicate contact lens wear

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 90

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to assess the safety and effectiveness of 3 different contact lens cleaning solutions in children over a long period of time. The study will take place in both Canada and the US. "This

Who is the study for?

This clinical trial is for children and teenagers who use contact lenses. They must be willing to follow the study's procedures, including using specific lens cleaning solutions provided by the trial. The exact age range and other specific health requirements are not listed here.

What is being tested?

The study tests three different OPTI-FREE products (EXPRESS, PureMoist, REPLENISH) used for cleaning and disinfecting contact lenses. Participants will use their usual contacts but switch between these solutions to see how they perform over time.

What are the potential side effects?

Potential side effects may include eye irritation or discomfort, allergic reactions to solution ingredients, or an increased risk of eye infections if the products do not clean effectively.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have any eye conditions that prevent me from wearing contact lenses.

Select...

I am not on any medication that prevents me from wearing contact lenses.

Select...

I regularly use eye drops or medication for my eyes that I would need to continue during the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 90

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 90

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 90 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Back surface deposits at Day 90

Front surface deposits at Day 90

Incidence of corneal infiltrative events

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Group I: OFR MPDSExperimental Treatment2 Interventions

OPTI-FREE REPLENISH MPDS and Alcon contact lens case used as instructed with habitual contact lenses for 90 days. It is expected that the habitual contact lenses will be worn for at least 8 hours per day for at least 5 days per week during study participation.

Group II: OFPM MPDSExperimental Treatment2 Interventions

OPTI-FREE PureMoist MPDS and Alcon contact lens case used as instructed with habitual contact lenses for 90 days. It is expected that the habitual contact lenses will be worn for at least 8 hours per day for at least 5 days per week during study participation.

Group III: OFE MPDSExperimental Treatment2 Interventions

OPTI-FREE EXPRESS MPDS and Alcon contact lens case used as instructed with habitual contact lenses for 90 days. It is expected that the habitual contact lenses will be worn for at least 8 hours per day for at least 5 days per week during study participation.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Habitual contact lenses

2014

N/A

~710

0 / 3Eligibility criteria met